Urokinase-type plasminogen activator receptor (uPAR) is a GPI-linked single chain glycoprotein that binds both the zymogen single chain pro-uPA and the enzymatically active two chain, high molecular weight uPA. uPAR has been found to be localized in sections of solid tumors of various human cancers and it is overexpressed in extracts of invasive breast, colorectal- and ovarian cancer tissues.
Swiss-Prot Accession Number: Q03405
A leading global drug discovery and development laboratory, IQVIA Laboratories (the laboratory business of IQVIA) provides customers with a comprehensive assemblage of solutions encompassing central laboratory and specialty biomarker services including genomics, immunoassays, flow cytometry, anatomic pathology, precision medicine assays, vaccine assays, ADME and bioanalytical along with extensive offerings in antibody drug discovery, biomarker discovery, and decentralized clinical trial lab solutions.
Learn more at labs.iqvia.com
Copyright 2025 Rules-Based Medicine. All rights reserved. RBM does not sell your personal information.